Sanofi announces positive data for frexalimab in relapsing MS
31st May 2023 Uncategorised 0The neurological disease affects approximately 2.8 million people worldwide
More: Sanofi announces positive data for frexalimab in relapsing MS
Source: News
The neurological disease affects approximately 2.8 million people worldwide
More: Sanofi announces positive data for frexalimab in relapsing MS
Source: News
© 1994 - 2026 B.M. Pharmaceuticals